Pharmaceutical industry
Health and Human Services Secretary Kathleen Sebelius urged nurses to be at the forefront of healthcare reform, acknowledging their critical role in the medical field. Meanwhile, the FDA approved Avastin for brain cancer treatment, Cycloset for type 2 diabetes, and a new gene linked to artery plaque ruptures was identified.
Pharmaceutical industry
The University of Barcelona (UB) has recently acquired a Genome Sequencer FLX System from 454 Life Sciences, a center of excellence of Roche Applied Science. This cutting-edge technology will be installed at the Genomics Unit of the Scientific and Technical Services (SCT) and will support over 110 research groups currently
Pharmaceutical industry
A recent wave of consolidation in the pharmaceutical industry is expected to benefit Indian contract manufacturers such as Piramal Healthcare, Jubilant Organosys, Divis' Labs, and Dishman Pharma. The consolidation is driven by global pharma companies' efforts to reduce costs and increase revenues, which could lead to more contract
Pharmaceutical industry
AVEO Pharmaceuticals has announced the initiation of a Phase 1b/2a clinical trial of AV-951 as monotherapy for the treatment of advanced non-small cell lung cancer (NSCLC). This trial builds on the company's broad development program for AV-951, a novel triple VEGF receptor inhibitor being studied in multiple
Pharmaceutical industry
The big pharma mergers and acquisitions have dominated the headlines lately, but a quieter consolidation is brewing in the biotech sector. With many small biotechs facing cash flow issues, experts predict a wave of acquisitions by larger biotechs or even midcap biotechs with cash reserves. Roche's recent buyout
Pharmaceutical industry
Roche, a leading biotechnology company, has submitted a marketing authorization application to the European Medicines Agency (EMEA) for Tarceva (erlotinib) as a first-line maintenance therapy for patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following first-line treatment with platinum-based chemotherapy. This development is part of Roche&
Pharmaceutical industry
The past week has brought much-needed gains for Wall Street, with the Dow, S&P 500, and Nasdaq all showing significant increases. Despite the rally, however, there is still uncertainty about the market's path forward, with potential pitfalls like bad news and short selling threatening to undo
Pharmaceutical industry
The week ending February 23 saw significant decline in equity markets, with the Dow Jones Industrial Average plummeting towards the 7,000 level, marking a 9.4% week-on-week drop. The lackluster fourth-quarter earnings reports from the biotechnology sector exacerbated the situation, with only four stocks recording gains while 29 others
Pharmaceutical industry
PDS Biotechnology, a biotechnology company based in Indiana, has announced a significant agreement with Merck Eprova AG, a subsidiary of Merck KGaA, located in Switzerland. The two companies have finalized a commercial licensing agreement that grants PDS Biotechnology exclusive rights to utilize Merck Eprova's proprietary chiral lipid DOTAP
Pharmaceutical industry
Cytokinetics, a biopharmaceutical company focused on muscle contractility, announced the delivery of clinical trials data for its novel cardiac myosin activator, CK-1827452, to Amgen, Inc. The data, which includes results from Phase I and IIa clinical trials, is expected to inform Amgen's decision to exercise its option to
Pharmaceutical industry
Teva Pharmaceutical Industries Ltd. and Clal Biotechnology Industries Ltd. announced that Teva will exercise its option to invest an additional $10.5 million in CBI's portfolio company, Andromeda Biotech Ltd., at a company value of $100 million. This investment is in addition to the $3 million Teva invested
Pharmaceutical industry
Response Genetics, Inc., a leader in molecular diagnostic testing for cancer, has signed a nonexclusive license with Roche Diagnostics to utilize their patented PCR analysis for assessing human epidermal growth factor type 2 (HER2) gene expression. This collaboration aims to enhance personalized medicine for cancer patients by providing accurate measurements
